
Meta $567 Million Fund: Does It Fix the Real Problem?
The headlines focus on the dollar figure. We ask whether a treatment fund actually addresses the platform-design problem the court itself identified.
HomePath Blog
No jargon, no pressure — just practical guidance for buying, refinancing, and understanding your options.

The headlines focus on the dollar figure. We ask whether a treatment fund actually addresses the platform-design problem the court itself identified.

HomePath Editorial draws a historical parallel to past public-health settlements — and explains why the itemized structure of this one might avoid an old mistake.

AMD's acquisition of Taalas brings a radically different approach to AI hardware — etching model weights directly into silicon. Here's what it does and why it's being read as a move against Nvidia.

This was the week's highest-engagement tech story on Hacker News, yet AMD's stock barely moved. We look at why that gap matters.

A three-way divergence between developer buzz, search demand, and stock price makes this story an unusually clean lesson in what different kinds of attention actually measure.